{"schema_version":"secwatch.filing_event.v1","accession":"0001326190-26-000056","form_type":"8-K","ticker":"ALT","cik":"0001326190","company_name":"Altimmune, Inc.","filed_at":"2026-09-29T11:03:49+00:00","discovered_at":"2026-09-29T11:05:00.177267+00:00","generated_at":"2026-10-12T13:41:31.211197+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Altimmune names Richard Menziuso VP, Global Controller and Principal Accounting Officer, effective Sept 29","bullets":["Richard Menziuso, 51, appointed Vice President, Global Controller and Principal Accounting Officer effective September 29, 2026; CFO Gregory Weaver remains in his role.","Menziuso was VP, Corporate Controller at Centessa Pharmaceuticals from 2021 until its 2026 acquisition by Eli Lilly; before that North America Controller at Thermo Fisher (2019-2021).","Earlier roles: VP, Accounting and Controller at Axovant Gene Therapies (2017-2019) and finance positions at LifeCell, ConvaTec, Tyco, PricewaterhouseCoopers and Bristol-Myers Squibb.","He brings 28 years of finance and accounting experience, including 12 in public accounting, and holds a B.B.A. from Pace University; he is a CPA and Chartered Global Management Accountant.","Company will enter an indemnification agreement with Menziuso mirroring those for other executive officers; no family relationships or Item 404(a) related-party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001326190-26-000056","json":"https://secwatch.observer/filing/0001326190-26-000056.json","markdown":"https://secwatch.observer/filing/0001326190-26-000056.md","text":"https://secwatch.observer/filing/0001326190-26-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326190/000132619026000056/0001326190-26-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326190/000132619026000056/alt-20260924x8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:41:31.211197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}